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SYRINGOCYSTADENOMA PAPILLIFERUM (SCAP) is a rare benign skin tumour believed to originate from the pluripotent cells and 
its histology exhibits either apocrine or eccrine 
sweat gland differentiation.1 The tumour appears 
predominantly in childhood; it appears at birth in 
approximately 50% of those affected and before 
puberty in a further 15–30%.2–4 However, in some 
cases it may appear at a later age.5 The tumour is more 
common in women than men.6 
The clinical presentation of SCAP is not distinctive 
and may often be misleading—it can present as a 
solitary patch, papule, plaque, nodule or as several 
papules often arranged linearly.7–9 The plaque type 
usually presents as a hairless area on the scalp, while 
the linear type appears on the face and neck region and 
the solitary nodular type shows a predilection for the 
trunk.8,9 The colour of the tumour varies from flesh-
coloured to pink, red, brown or grey.6,10 Its surface may 
be smooth, hyperkeratotic, verrucous, papillary or 
moist and fleshy. The tumour tends to grow slowly and 
is usually less than 4 cm in size.4 
While the clinical features of SCAP vary widely, 
its histology is invariably uniform and confirmatory.7 
Although the lesion is benign, transformation to 
basal cell carcinoma, metastatic adenocarcinoma or 
ductal carcinoma may occur.5,8,11 An unusual case of 
this entity occurring on the upper lip is documented 
below. To date, only three cases involving the upper lip 
have been reported in the literature.5
Case Report
A 10-year-old girl presented to the Sultan Qaboos 
University Hospital in Muscat, Oman, in February 
2012 with a non-tender, non-pruritic, solitary 
verrucous papule on the left side of the upper lip. The 
papule had been present since birth and was associated 
with recurrent ulceration and bleeding. It had been 
slowly increasing in size over time. She had consulted 
many different physicians but no definite diagnosis 
had been made. Numerous treatments had been 
attempted without success, including scraping the 
lesion on a number of occasions and the application 
of various topical medications, including traditional 
medicinal treatments. There was no other significant 
past medical history.
A physical examination revealed a solitary painless 
raised papule of 4 x 5 mm on the left side of the upper 
lip, with an area of surrounding blood clots [Figure 1]. 
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abstract: Syringocystadenoma papilliferum (SCAP) is a rare skin tumour believed to arise from the apocrine or 
eccrine sweat glands. It appears predominantly in childhood, usually at birth. It is exceedingly rare for it to appear on 
the upper lip. We report a case of SCAP in a 10-year-old Omani girl who presented to the Sultan Qaboos University 
Hospital in Muscat, Oman, in February 2012 with a non-tender, non-pruritic, solitary verrucous papule of 4 x 5 mm 
on the left side of the upper lip. It had been present since birth and had slowly been increasing in size over the years. 
It was occasionally associated with recurrent ulceration and bleeding and had previously been misdiagnosed and 
mismanaged. An excisional biopsy was performed and the whole lesion was removed. The surgical site was then 
sutured and the patient was discharged on the same day.
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امللخ�ص: ورم الغدد العرقية احلليمي ورم جلدي نادر ي�سيب الغدد العرقية املفرتزة والفارزة يف اجللد. غالبا ما يظهر يف الطفولة عادة عند الوالدة. نادرا 
جدا ما يظهر هذا الورم على ال�سفاه العليا. يف هذا املقال نقدم تقريرا عن طفلة عمانية تبلغ من العمر 10 �سنوات زارت م�ست�سفى جامعة ال�سلطان قابو�س يف 
م�سقط، عمان يف فرباير 2012 وعليها ورم ثوؤلويل منفرد )5 × 4 مم( ، غري موؤمل  وبغري حكة على اجلانب االأي�رس من ال�سفة العليا كان قد ظهر منذ الوالدة. 
ازداد حجم الورم ببطء على مدى ال�سنني مع تقرح ونزيف متكرر. مل تكن حماوالت ت�سخي�سه وعالجه ال�سابقة ناجحة. مت اإجراء خزعة ا�ستئ�سالية ومتت اإزالة 
التقرح كله. مت تخييط املوقع اجلراحي وخرجت املري�سة يف اليوم نف�سه.
مفتاح الكلمات: االأورام اجللدية؛ غدد العرق؛ ال�سفة العليا؛ الت�سخي�س اخلاطئ؛ �رسطان اخلاليا القاعدية؛ تقرير حالة؛ عمان.
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No other abnormalities were detected around the 
lesion or on any other parts of the body.
An initial diagnosis of a granuloma was made. 
An excisional biopsy was performed and the whole 
lesion was removed and sent for a histopathology 
examination. The defect was then closed with a suture 
and the patient was discharged on the same day. 
The pathological findings revealed a gross specimen 
measuring 15 x 5 x 3 mm, consisting of multiple 
fragments of soft tissue. The specimen was processed 
using a Haematoxylin and Eosin stain. Microscopically, 
a biopsy determined that the specimen was comprised 
of epidermal, dermal and skeletal muscle cells. 
The epidermis was hyperplastic, showing cystic 
invagination into the dermis, with infiltration of the 
lymphocytes and neutrophils [Figure 2]. In the lower 
part of the epidermis, a lesion was observed. The 
lesion was composed of a few papillary projections 
and ducts/gland-like structures lined by luminal and 
cuboidal cells. The papillary projections were lined by 
double epithelial cells with an abundance of plasma cell 
infiltrates in their cores [Figures 3 and 4]. No atypia or 
mitosis was seen. The overall architecture of the lesion 
revealed an invagination from the epidermis with 
overlying squamous hyperplasia, papillary projections 
lined by double epithelial cells and infiltration of the 
plasma cells. This morphology was consistent with a 
diagnosis of SCAP.
Discussion
SCAP is a rare benign tumour of the skin, usually 
seen in patients at birth or during infancy or early 
childhood. Most lesions are not distinctive and require 
a biopsy for the diagnosis; however, the tumour is 
usually described as ranging from skin-coloured to 
pink, and taking the form of either a hairless firm 
plaque, grouped nodules or a solitary nodule.12 
Figure 1: Photograph of a non-tender, non-pruritic 
solitary verrucous papule on the left side of the upper 
lip of a 10-year-old girl. This papule had been present 
since birth.
Figure 2: Histopathology of the skin lesion showing 
the cystic invagination of the epidermis with papillary 
projections (black arrows) and duct-like structures 
(white arrows). The specimen was processed using 
Hematoxylin and Eosin stain at x5 magnification.
Figure 3: Duct-like structures (white arrows) and 
papillary projections (black arrows) lined by double 
epithelial cells can be observed. Plasma cells are visible 
in the cores (arrow heads). The specimen was processed 
using hematoxylin and eosin stain at x20 magnification.
Figure 4: Histopathology indicated an abundance of 
plasma cells (white arrows). The specimen was processed 
using hematoxylin and eosin stain at x20 magnification.
Hamdan A. Al-Habsi, Mustafa Al-Hinai, Ahmed Al-Waily, Salim Al-Sudairy and Vipula de Silva
Online Case Report | e577
The differential diagnosis of SCAP is broad. It can 
include nevus sebaceous, hidradenoma papilliferum, 
molluscum contagiosum, verruca vulgaris, squa-
mous cell carcinoma, keratoacanthoma and basal cell 
carcinoma.4,13 
The clinical presentation of the tumour is non- 
specific and can resemble any of the aforementioned 
conditions;7,8 however, the histopathological features 
are specific and diagnostic. The tumour histology 
shows characteristic epidermal cystic invaginations 
into the dermis, papillary projections and abundant 
plasma cell infiltration.2,8,10 The invaginations are 
lined by a double layer of epithelial cells, whereas the 
papillary projections are lined by glandular epithelium 
which often exhibits decapitation secretion.4,8,10 
Immunohistochemical studies using epithelial 
membrane antigen and cytokeratin markers show 
that the epithelium is composed of several cell types 
at different stages of development, with a tendency 
to differentiate toward the basal cells in the apocrine 
lineage or luminal cells in the secretory epithelium.1,11,14 
The results of these studies support the theory that 
SCAP is a tumour originating from the pluripotent 
cells. 
Cases of SCAP are sporadic and most commonly 
seen in the scalp region. They are only rarely described 
in other parts of the body.4,10,13 It is hoped that this 
report will add to the available information on SCAP 
involving the upper lip. An extensive search of the 
literature has shown that only three similar cases have 
been documented so far. 
Although this lesion is benign, a transformation 
to basal cell carcinoma, metastatic adenocarcinoma 
or ductal carcinoma may still occur.15,16 SCAP has 
been associated with basal cell carcinoma in about 
10% of cases.7,10 Squamous cell carcinoma may also 
develop, but much less frequently. Other malignant 
tumours associated with SCAP include verrucous and 
ductal carcinomas.16 Rapid growth, pain, ulceration 
or bleeding in a long-standing lesion may indicate a 
malignant transformation to syringocystadenocarci 
noma papilliferum.6,16 
Conclusion
SCAP is an uncommon tumour and its appearance 
on the upper lip is very rare. The clinical presentation 
of this tumour resembles many other skin lesions. It 
should be considered in the differential diagnosis of any 
long-standing plaque or nodular lesion, particularly 
if there is an increase in size or the occurrence 
of ulceration and/or bleeding. The tumour has 
characteristic histological features which can be used 
as the basis for diagnosis. Malignant transformation 
can occur; a complete excision of the lesion is therefore 
the treatment of choice. 
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